๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Altered metastatic behavior of small cell carcinoma of the lung after chemotherapy and radiation

โœ Scribed by Suzanne M. La De Monte; Grover M. Hutchins; G. William Moore

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
730 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy and radiation t
Combination chemotherapy and radiation therapy in small cell carcinoma of the lung
โœ Robert T. Eagan; L. Herbert Maurer; R. Jackson Forcier; Marchant Tulloh ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 786 KB

Twenty-eight patients with small cell carcinoma of the lung were studied for their response to combination chemotherapy and radiation therapy, frequency of bone marrow metastases, and clinically evident hormonal syndromes. Seventeen of 19 evaluable patients who received cyclic monthly courses of hig

Comparison of chemotherapy alone versus
Comparison of chemotherapy alone versus chemotherapy and radiation therapy of extensive small cell carcinoma of the lung
โœ Henry E. Wilson; Kenneth Stanley; Ronald G. Vincent; Clifton F. Mountain; Rossal ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 391 KB

In a randomized study 145 patients with extensive small cell carcinoma of the lung were treated with chemotherapy alone (Cytoxan, CCNU, methotrexate) or with the same drug regimen and with radiation therapy to the brain, chest, and abdomen. One hundred eighteen of these patients were evaluable. Thos

Combination radiotherapy and chemotherap
Combination radiotherapy and chemotherapy for small cell carcinoma of the lung
โœ Goldberg, R. S. ;Joss, R. A. ;Bedwinek, J. ;Yates, J. W. ;Krakoff, I. H. ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 319 KB

Twenty previously untreated patients with small cell carcinoma of the lung were treated with cyclophosphamide, 400 mg/m2 and Adriamycin, 40 mg/m2 IV on day 1, followed by cytosine arabinoside, 20 mg/m2, every 12 hours subcutaneously on days 5--9; this regimen was repeated every 28 days. On days 14--